ABEONA THERAPEUTICS INC.
ABEO US00289Y2063
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Seshadri Vishwas CEO |
5.24 USD |
25,000 Sold |
130,930 USD |
29/09/2025 | 30/09/2025 |
O'malley Brendan M. VP |
5.39 USD |
9,366 Sold |
50,516 USD |
29/09/2025 | 29/09/2025 |
Seshadri Vishwas CEO |
5.39 USD |
19,274 Sold |
103,954 USD |
29/09/2025 | 29/09/2025 |
Vazzano Joseph Walter CFO |
5.39 USD |
9,035 Sold |
48,730 USD |
29/09/2025 | 29/09/2025 |
O'malley Brendan M. VP |
5.43 USD |
688 Sold |
3,736 USD |
22/09/2025 | 22/09/2025 |
Vazzano Joseph Walter CFO |
7.36 USD |
15,000 Sold |
110,358 USD |
15/08/2025 | 15/08/2025 |
Crombez Eric O |
6.93 USD |
4,718 Sold |
32,683 USD |
14/08/2025 | 14/08/2025 |
Vazzano Joseph Walter CFO |
6.64 USD |
1,502 Sold |
9,975 USD |
22/07/2025 | 22/07/2025 |
Alvino Mark O |
5.86 USD |
13,093 Sold |
76,669 USD |
09/07/2025 | 09/07/2025 |
Charles Faith L. O |
5.86 USD |
10,738 Sold |
62,879 USD |
09/07/2025 | 09/07/2025 |